Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cell Therapeutics submits NDA for arsenic trioxide

March 31, 2000

Breast cancer trial of annamycin commenced by Aronex

March 31, 2000

UroGen awarded SBIR grant to support prostate cancer gene therapy product development

March 31, 2000

Phase I/II clinical trial data reported for MTC-DOX in liver cancer

March 31, 2000

Clinical trial of STR in Ewing's sarcoma initiated by NeoRx

March 30, 2000

New farnesyltransferase inhibitor L-779575 presented by Merck this week

March 29, 2000

ACS news: BMS presents potent new inhibitor of cyclin-dependent kinases

March 29, 2000

Kinetek validates ILK inhibition as potential cancer therapy

March 29, 2000

NCI initiates third phase II trial of O6-benzylguanine in combination with BCNU

March 29, 2000

Cell Therapeutics to submit NDA for arsenic trioxide by the end of March

March 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...